RU2000108989A - METHOD FOR PREVENTION AND TREATMENT OF CAVIAR RESPIRATORY DISEASES - Google Patents

METHOD FOR PREVENTION AND TREATMENT OF CAVIAR RESPIRATORY DISEASES

Info

Publication number
RU2000108989A
RU2000108989A RU2000108989/13A RU2000108989A RU2000108989A RU 2000108989 A RU2000108989 A RU 2000108989A RU 2000108989/13 A RU2000108989/13 A RU 2000108989/13A RU 2000108989 A RU2000108989 A RU 2000108989A RU 2000108989 A RU2000108989 A RU 2000108989A
Authority
RU
Russia
Prior art keywords
prevention
treatment
respiratory diseases
caviar
twice
Prior art date
Application number
RU2000108989/13A
Other languages
Russian (ru)
Other versions
RU2189811C2 (en
Inventor
Павел Николаевич Сисягин
Гуля Реджеповна Реджепова
Ирина Васильевна Убитина
Мария Владимировна Сухова
Валерий Алексеевич Душкин
Original Assignee
Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ
Filing date
Publication date
Application filed by Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ filed Critical Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ
Priority to RU2000108989A priority Critical patent/RU2189811C2/en
Priority claimed from RU2000108989A external-priority patent/RU2189811C2/en
Publication of RU2000108989A publication Critical patent/RU2000108989A/en
Application granted granted Critical
Publication of RU2189811C2 publication Critical patent/RU2189811C2/en

Links

Claims (2)

1. Способ профилактики и лечения респираторных болезней телят, включающий применение сульфацина и повышающего резистентность организма препарат, отличающийся тем, что в качестве повышающего резистентность организма препарата используют 1,1-диметил-3-оксопиразолидин-1-ий-4-ил ацетат (квациклин) в форме 2%-ного раствора, который вводят внутримышечно однократно и повторно двукратно с интервалом 5 дней в дозе 5,0-6,0 мл.1. A method for the prevention and treatment of calf respiratory diseases, including the use of sulfacin and a drug that increases body resistance, characterized in that 1,1-dimethyl-3-oxopyrazolidin-1-y-4-yl acetate (quacycline) is used to increase the body's resistance to the drug ) in the form of a 2% solution, which is administered intramuscularly once and twice twice with an interval of 5 days in a dose of 5.0-6.0 ml. 2. Способ по п. 1, отличающийся тем, что в качестве повышающего резистентность организма препарата используют 1,2-(триметиламмонио)этилкарбамат (изокватерин) в форме 10%-ного раствора, который вводят внутримышечно однократно и повторно двукратно с интервалом 5 дней в дозе 1,0-1,5 мл. 2. The method according to p. 1, characterized in that 1,2- (trimethylammonio) ethyl carbamate (isoquaterine) is used in the form of a 10% solution, which is administered intramuscularly once and twice twice with an interval of 5 days dose of 1.0-1.5 ml.
RU2000108989A 2000-04-10 2000-04-10 Method for prophylaxis and treatment of respiratory diseases in calves RU2189811C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2000108989A RU2189811C2 (en) 2000-04-10 2000-04-10 Method for prophylaxis and treatment of respiratory diseases in calves

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2000108989A RU2189811C2 (en) 2000-04-10 2000-04-10 Method for prophylaxis and treatment of respiratory diseases in calves

Publications (2)

Publication Number Publication Date
RU2000108989A true RU2000108989A (en) 2002-05-20
RU2189811C2 RU2189811C2 (en) 2002-09-27

Family

ID=20233153

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000108989A RU2189811C2 (en) 2000-04-10 2000-04-10 Method for prophylaxis and treatment of respiratory diseases in calves

Country Status (1)

Country Link
RU (1) RU2189811C2 (en)

Similar Documents

Publication Publication Date Title
EA200000468A1 (en) THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY
DE60316779D1 (en) THIADIAZOLYLPIPERAZINE DERIVATIVES SUITABLE FOR THE TREATMENT OF BZW. PREVENTION OF PAIN
JP2002522485A5 (en)
ATE493981T1 (en) ONCE DAILY DOSAGE FORMS OF TROSPIUM
RU2005126412A (en) COP1 FOR TREATMENT OF INFLAMMATORY DISEASES OF THE INTESTINE
JP2004537500A5 (en)
JP2003514025A5 (en)
DK0738147T3 (en) Use of riluzole in the treatment of mitochondrial diseases
KR930019224A (en) Abortion Hazard Remedy
ATE192926T1 (en) COMPOSITION CONTAINING FLAVOPEREIRINE AND ITS USE IN THE TREATMENT AGAINST HIV VIRUSES
RU2002129298A (en) APPLICATION OF GALANTAMINE FOR THE TREATMENT OF PSYCHONEUROLOGICAL BEHAVIOR ASSOCIATED WITH ALZHEIMER'S DISEASE
RU2000108989A (en) METHOD FOR PREVENTION AND TREATMENT OF CAVIAR RESPIRATORY DISEASES
TW200517119A (en) Method of treatment using interferon-tau
WO2002006343A3 (en) Composition for treatment of and method of monitoring hepatitis c virus using interferon-tau
DE69925312D1 (en) BUPROPION FOR THE TREATMENT OF VIRAL DISEASES
RU2005131943A (en) MEDICINAL AND / OR PREVENTIVE MEANS FOR CHRONIC SKIN DISEASES
EA199800770A1 (en) DRUGS FOR THERAPEUTIC TREATMENT OF VIRAL HEPATITIS
WO2002030955A3 (en) Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use
ATE454397T1 (en) TETRAPEPTIDE REGULATING THE BLOOD SUGAR LEVEL IN DIABETES MELLITUS
DE60202299D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING SALMETEROL AND BUDESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES
RU2001113054A (en) A method for the treatment of postpartum acute purulent-catarrhal endometritis of cows
RU2002129102A (en) TREATMENT OF SEPARATE DOSES OF AGENTS WITH VASCULAR DESTRUCTIVE ACTIVITY
RU2001102089A (en) METHOD FOR TREATMENT OF DISCIRCULATORY ENCEPHALOPATHY
RU2001124669A (en) Method for the prevention of calf paratyphoid
TH54147A (en) Mycophenolate Mofitilano to join with PEG-IFN-Alpha